细菌内毒素-脂多多糖在炎症性疾病中的作用:概述
Priyanka Arya1, Vikram Sharma1, Priyanka Singh2
1Galgotias College of Pharmacy, Greater Noida, U.P., India.
Iranian journal of basic medical sciences
|July 16, 2025
概括
细菌脂多糖 (LPS) 引发有害的炎症,导致癌症和神经退行等疾病. 了解LPS途径为新的抗炎治疗提供了目标.
科学领域:
- 免疫学 免疫学 免疫学
- 病原体生物学 病原体生物学
- 分子医学是分子医学.
背景情况:
- 炎症带来了重大的医疗挑战,从败血症休克到慢性组织退化.
- 脂聚糖 (LPS) 是格拉姆阴性细菌的组成部分,是炎症反应的强有力的触发剂.
- LPS激活免疫和非免疫细胞,导致有害的炎症过程和疾病.
研究的目的:
- 审查脂多糖 (LPS) 导致各种炎症疾病的机制.
- 探索LPS在启动和加剧炎症状况中的作用.
- 在LPS信号通路中识别潜在的治疗点.
主要方法:
- 文献综述侧重于LPS介导的炎症.
- 分析涉及LPS激活免疫和非免疫细胞的分子机制.
- 检查由LPS调节的细胞内信号通路.
主要成果:
- LPS激活病原体相关的分子模式 (PAMPs),刺激先天免疫系统.
- LPS调节细胞内分子,影响炎症介质的表达,并加剧炎症.
- 过度的LPS诱导的炎症与慢性疾病有关,包括神经退行性疾病,心血管疾病和癌症.
结论:
- LPS是广泛的炎症性疾病的关键贡献者.
- 针对LPS信号通路,包括TLR4,NLRP3,HMGA1,MAPK和NF-kB,提供了有前途的治疗策略.
- 了解LPS机制对于开发炎症相关疾病的精确治疗至关重要.
相关概念视频
Formation of Lipopolysaccharides
104
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
104
Inflammation
55.3K
Overview
55.3K
Inflammatory Response
7.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.9K
Inflammatory Bowel Disease II: Crohn's Disease
392
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
392
Irritable Bowel Syndrome I: Introduction
393
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
393
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
237
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
237


